Publication | Open Access

Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Managed Care Perspective: The ISPOR Drug Cost Task Force Report—Part III

Cost-effectiveness AnalysisHealth EconomicsHealth PolicyHealth Care ReimbursementCost-effectiveness AnalysesOutcomes ResearchEconomic EvaluationAddiction MedicineDrug CostsManaged Care PerspectivePharmacoeconomicsCost EffectivenessHealth Care CostPublic HealthManaged CareMedicineHealth Services Research